|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.78 SEK | -3.14% |
|
-13.52% | -3.14% |
| Apr. 02 | ChromoGenics AB Receives First Order for North America | CI |
| Mar. 08 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ChromoGenics AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 6.4 million compared to SEK 9.16 million a year ago. Revenue was SEK 6.75 million compared to SEK 9.28 million a year ago.
Net loss was SEK 13.09 million compared to SEK 17.6 million a year ago. Basic loss per share from continuing operations was SEK 9 compared to SEK 91 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.14% | 4.1M | |
| +18.22% | 7.17B | |
| +5.12% | 2.36B | |
| +6.58% | 1.02B | |
| +22.43% | 817M | |
| 0.00% | 404M | |
| +4.88% | 362M | |
| +7.79% | 231M | |
| +14.62% | 192M | |
| +11.11% | 169M |
CHROMOGENICS AB 
